Nuclear Fragile X Mental Retardation Protein Interacting Protein 2 (NUFIP2) Peptide
NUFIP2
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all NUFIP2 products
- NUFIP2 (Nuclear Fragile X Mental Retardation Protein Interacting Protein 2 (NUFIP2))
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-NUFIP2 antibody (Catalog #: ARP51676_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- NUFIP2 (Nuclear Fragile X Mental Retardation Protein Interacting Protein 2 (NUFIP2))
- Background
-
NUFIP2 binds RNA. It is phosphorylated upon DNA damage, probably by ATM or ATR. The exact functions of NUFIP2 remain unknown.
Alias Symbols: 182-FIP, 82-FIP, FIP-82, FLJ10976, KIAA1321, MGC117262, PIG1
Protein Interaction Partner: FMR1,YWHAG,FMR1,G3BP1,G3BP2
Protein Size: 695 - Molecular Weight
- 76 kDa
- Gene ID
- 57532
- NCBI Accession
- NM_020772, NP_065823
- UniProt
- Q7Z417
-
You are here:
